SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosa tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Astraveus SAS ("Astraveus" or the "Company"), the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT).
Paris, France, December 7, 2021 – Advent France Biotechnology (AFB), an AMF-regulated (the French financial market authority) investment company dedicated to life sciences, today announces it is changing its company name to AdBio partners. The name change embodies AdBio partners’ strong will and determination to add.
A team of researchers has published an article in <i>Nature Communications</i> showing the potential of Find Cut-and-Transfer (FiCAT) technology as a state-of-the-art tool for gene writing to develop advanced therapies.